Monthly
US$200
Billed every month
Sodium Bicarbonate Injection(碳酸氢钠注射液)
Companies, stages and changes, with each record available on this page.
Last 90 days: Marketing application approved: 1 applicationAccepted: 4 applicationsNo longer listed under review: 1 applicationSupplement delivery: 1 application
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Company names, approval identifiers and strengths are retained as recorded in the Chinese sources. Category labels include the original wording for verification.
Catalogue holders40View records ↓
Under-review filings10View records ↓
This year’s generic filers2View records ↓
NHSA approval numbers150View records ↓
API companies with A status17View records ↓
Chemical-drug catalogue
Loaded records: 40 holders; 21 in the quality-and-efficacy consistency-evaluation category, and 20 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| 漯河市汇创医药有限公司 | 广东星昊药业有限公司 | 国药准字H20266020 | 2026/09/15 | 10ml︰0.84g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 漯河市汇创医药有限公司 | 广东星昊药业有限公司 | 国药准字H20266021 | 2026/09/15 | 10ml︰0.42g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 上海浦津林州制药有限公司 | 上海浦津林州制药有限公司 | 国药准字H20269220 | 2026/08/31 | 10ml：0.84g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 回音必集团江西东亚制药有限公司 | 回音必集团江西东亚制药有限公司 | 国药准字H20269156 | 2026/07/07 | 50ml:4.2g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 江西泰吉立生物医药科技有限公司 | 浙江赛默制药有限公司 | 国药准字H20265025 | 2026/06/30 | 10ml：0.84g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江西泰吉立生物医药科技有限公司 | 浙江赛默制药有限公司 | 国药准字H20265024 | 2026/06/30 | 10ml：0.42g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东齐都药业有限公司 | 山东齐都药业有限公司 | 国药准字H20269146 | 2026/06/29 | 100ml:1.4g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 北京民康百草医药科技有限公司 | 武汉福星生物药业有限公司 | 国药准字H20264840 | 2026/06/17 | 100ml:1.4g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江苏宝东医药科技有限公司 | 江苏大红鹰恒顺药业有限公司 | 国药准字H20264711 | 2026/06/10 | 50ml:4.2g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 沈药合泽药业（山东）有限公司 | 广东星昊药业有限公司 | 国药准字H20264610 | 2026/06/03 | 10ml：0.42g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 海南爱科制药有限公司 | 海南爱科制药有限公司 | 国药准字H20264597 | 2026/06/03 | 100ml：1.4g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 湖北多瑞药业有限公司 | 湖北多瑞药业有限公司 | 国药准字H20264550 | 2026/05/27 | 100ml∶1.4g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 南京赛瑞谱顿制药有限公司 | 江苏大红鹰恒顺药业有限公司 | 国药准字H20264064 | 2026/04/21 | 10ml:0.42g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 南京赛瑞谱顿制药有限公司 | 江苏大红鹰恒顺药业有限公司 | 国药准字H20264065 | 2026/04/21 | 10ml:0.84g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 成都欣捷高新技术开发股份有限公司 | 成都天台山制药股份有限公司 | 国药准字H20263843 | 2026/04/07 | 10ml∶0.42g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江西东抚制药有限公司 | 江西东抚制药有限公司 | 国药准字H20263701 | 2026/03/25 | 10ml：0.42g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 陕西丽彩药业有限公司 | 江苏大红鹰恒顺药业有限公司 | 国药准字H20263613 | 2026/03/17 | 50ml:4.2g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 陕西丽彩药业有限公司 | 江苏大红鹰恒顺药业有限公司 | 国药准字H20263612 | 2026/03/17 | 10ml:0.42g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 绪必迪药业（河北）有限公司 | 山西普德药业有限公司 | 国药准字H20256299 | 2025/12/16 | 10ml：0.84g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 杭州民生药业股份有限公司 | 杭州民生药业股份有限公司 | 国药准字H20255855 | 2025/11/04 | 50ml：4.2g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 广东星昊药业有限公司 | 广东星昊药业有限公司 | 国药准字H20255851 | 2025/11/04 | 10ml：0.84g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 国药集团容生制药有限公司 | 国药集团容生制药有限公司 | 国药准字H20258193 | 2025/09/10 | 10ml：0.84g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 山东华鲁制药有限公司 | 山东华鲁制药有限公司 | 国药准字H20258191 | 2025/09/10 | 10ml：0.42g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 山东华鲁制药有限公司 | 山东华鲁制药有限公司 | 国药准字H20258190 | 2025/09/10 | 10ml：0.84g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 江西璟瑞药业有限公司 | 江西东抚制药有限公司 | 国药准字H20255390 | 2025/09/09 | 10ml：0.42g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 湖北天圣药业有限公司 | 湖北天圣药业有限公司 | 国药准字H20258187 | 2025/09/09 | 10ml:0.42g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 南京恩泰医药科技有限公司 | 江苏九旭药业有限公司 | 国药准字H20255298 | 2025/09/02 | 10ml:0.84g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 北京民康百草医药科技有限公司 | 山西诺成制药有限公司 | 国药准字H20255278 | 2025/09/02 | 10ml:0.42g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江苏正大丰海制药有限公司 | 江苏正大丰海制药有限公司 | 国药准字H20258141 | 2025/07/24 | 50ml：4.2g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 石药银湖制药有限公司 | 石药银湖制药有限公司 | 国药准字H20258113 | 2025/06/24 | 10ml:0.84g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 广州合和医药有限公司 | 广东星昊药业有限公司 | 国药准字H20254426 | 2025/06/03 | 10ml︰0.42g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 合肥源丰顺医药科技有限公司 | 湖南科伦制药有限公司 | 国药准字H20258082 | 2025/05/19 | 10ml:0.84g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 合肥源丰顺医药科技有限公司 | 湖南科伦制药有限公司 | 国药准字H20258083 | 2025/05/19 | 10ml:0.42g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 河北天成药业股份有限公司 | 河北天成药业股份有限公司 | 国药准字H20258043 | 2025/03/25 | 50ml：4.2g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 石家庄四药有限公司 | 石家庄四药有限公司 | 国药准字H20253723 | 2025/03/25 | 10ml：0.42g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 广东科泓药业有限公司 | 湖南科伦制药有限公司 | 国药准字H20258026 | 2025/03/10 | 50ml:4.2g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 石家庄四药有限公司 | 石家庄四药有限公司 | 国药准字H20253531 | 2025/03/04 | 10ml：0.84g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 华夏生生药业（北京）有限公司 | 华夏生生药业（北京）有限公司 | 国药准字H20253516 | 2025/03/04 | 10ml∶0.84g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 四川太平洋药业有限责任公司 | 四川太平洋药业有限责任公司 | 国药准字H20258022 | 2025/02/27 | 50ml:4.2g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 海南倍特药业有限公司 | 海南倍特药业有限公司 | 国药准字H20258018 | 2025/02/19 | 10ml:0.42g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 海南倍特药业有限公司 | 海南倍特药业有限公司 | 国药准字H20258017 | 2025/02/19 | 10ml:0.84g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 湖南科伦制药有限公司 | 湖南科伦制药有限公司 | 国药准字H20258007 | 2025/01/09 | 10ml:0.42g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 湖南科伦制药有限公司 | 湖南科伦制药有限公司 | 国药准字H20258008 | 2025/01/09 | 10ml:0.84g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 河北天成药业股份有限公司 | 河北天成药业股份有限公司 | 国药准字H20258009 | 2025/01/09 | 10ml：0.42g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 河北天成药业股份有限公司 | 河北天成药业股份有限公司 | 国药准字H20258004 | 2025/01/09 | 10ml：0.84g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 黑龙江博宇制药有限公司 | 四川科伦药业股份有限公司 | 国药准字H20258006 | 2025/01/09 | 50ml：4.2g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 华润双鹤利民药业（济南）有限公司 | 华润双鹤利民药业（济南）有限公司 | 国药准字H20258005 | 2025/01/09 | 10ml:0.84g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 辽宁民康制药有限公司 | 湖南科伦制药有限公司 | 国药准字H20247327 | 2024/12/24 | 50ml：4.2g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 昆明南疆制药有限公司 | 四川科伦药业股份有限公司 | 国药准字H20247291 | 2024/11/21 | 50ml：4.2g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 山东齐都药业有限公司 | 山东齐都药业有限公司 | 国药准字H20247251 | 2024/10/23 | 50ml:4.2g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 哈尔滨三联药业股份有限公司 | 哈尔滨三联药业股份有限公司 | 国药准字H20247252 | 2024/10/23 | 10ml：0.84g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 山东齐都药业有限公司 | 山东齐都药业有限公司 | 国药准字H20247233 | 2024/09/30 | 10ml：0.84g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 山东齐都药业有限公司 | 山东齐都药业有限公司 | 国药准字H20247232 | 2024/09/30 | 10ml：0.42g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 嘉实（湖南）医药科技有限公司 | 湖南康源制药有限公司 | 国药准字H20244838 | 2024/09/10 | 100ml:1.4g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东新华制药股份有限公司 | 山东新华制药股份有限公司 | 国药准字H20227054 | 2024/05/23 | 10ml：0.84g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 石家庄四药有限公司 | 石家庄四药有限公司 | 国药准字H20247111 | 2024/05/23 | 50ml：4.2g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 150 distinct approval numbers and 91 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| 广东星昊药业有限公司 | 国药准字H20255851 | 10ml:0.84g | Category A (甲) | XB05XAT018B002010100198 | NHSA |
| 东莞市普济药业有限公司 | 国药准字H20064481 | 250ml:12.5g | Category A (甲) | XB05XAT018B002010100251 | NHSA |
| 广东雷允上药业有限公司 | 国药准字H44023752 | 250ml:12.5g | Category A (甲) | XB05XAT018B002010100365 | NHSA |
| 津药和平(天津)制药有限公司 | 国药准字H12020998 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010100874 | NHSA |
| 中国大冢制药有限公司 | 国药准字H20183434 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010100967 | NHSA |
| 西南药业股份有限公司 | 国药准字H50020065 | 250ml:12.5g | Category A (甲) | XB05XAT018B002010100978 | NHSA |
| 天圣制药集团股份有限公司 | 国药准字H20057634 | 100ml:5g | Category A (甲) | XB05XAT018B002010101055 | NHSA |
| 重庆药友制药有限责任公司 | 国药准字H50020782 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010101066 | NHSA |
| 辽宁民康制药有限公司 | 国药准字H20247327 | 50ml:4.2g | Category A (甲) | XB05XAT018B002010101227 | NHSA |
| 江苏淮安双鹤药业有限责任公司 | 国药准字H32022428 | 100ml:5g | Category A (甲) | XB05XAT018B002010101449 | NHSA |
| 江苏正大丰海制药有限公司 | 国药准字H32026207 | 250ml:12.5g | Category A (甲) | XB05XAT018B002010101521 | NHSA |
| 海南倍特药业有限公司 | 国药准字H32022332 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010101708 | NHSA |
| 武汉福星生物药业有限公司 | 国药准字H42022237 | 250ml :12.5g | Category A (甲) | XB05XAT018B002010101799 | NHSA |
| 湖北济得药业有限公司 | 国药准字H20043461 | 250ml:12.5g | Category A (甲) | XB05XAT018B002010101803 | NHSA |
| 湖北天圣药业有限公司 | 国药准字H42020420 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010101842 | NHSA |
| 武汉爱民制药股份有限公司 | 国药准字H42021873 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010101924 | NHSA |
| 武汉滨湖双鹤药业有限责任公司 | 国药准字H42020468 | 250ml∶12.5g | Category A (甲) | XB05XAT018B002010101927 | NHSA |
| 武汉久安药业有限公司 | 国药准字H42021734 | 100ml:5g | Category A (甲) | XB05XAT018B002010101949 | NHSA |
| 成都第一制药有限公司 | 国药准字H51022125 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010102065 | NHSA |
| 四川美大康华康药业有限公司 | 国药准字H51021422 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010102087 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20043738 | 100ml:5g | Category A (甲) | XB05XAT018B002010102180 | NHSA |
| 四川美大康佳乐药业有限公司 | 国药准字H20044247 | 250ml:12.5g | Category A (甲) | XB05XAT018B002010102189 | NHSA |
| 四川太平洋药业有限责任公司 | 国药准字H20258022 | 50ml:4.2g | Category A (甲) | XB05XAT018B002010102261 | NHSA |
| 陕西同康药业有限公司 | 国药准字H61020268 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010102434 | NHSA |
| 西安京西双鹤药业有限公司 | 国药准字H61020138 | 100ml:5g | Category A (甲) | XB05XAT018B002010102492 | NHSA |
| 河北美图制药有限责任公司 | 国药准字H13022003 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010102598 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H13022134 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010102662 | NHSA |
| 石家庄四药有限公司 | 国药准字H13023197 | 250ml:12.5g | Category A (甲) | XB05XAT018B002010102763 | NHSA |
| 河北天致药业有限公司 | 国药准字H13021829 | 250ml:12.5g | Category A (甲) | XB05XAT018B002010102783 | NHSA |
| 山西华卫药业有限公司 | 国药准字H14023901 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010102887 | NHSA |
| 山西太原药业有限公司 | 国药准字H14022070 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010102944 | NHSA |
| 石药银湖制药有限公司 | 国药准字H14022190 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010102954 | NHSA |
| 石药银湖制药有限公司 | 国药准字H20258113 | 10ml:0.84g | Category A (甲) | XB05XAT018B002010102964 | NHSA |
| 上海锦帝九州药业(安阳)有限公司 | 国药准字H41023047 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010102994 | NHSA |
| 郑州卓峰制药有限公司 | 国药准字H41025292 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010103013 | NHSA |
| 河南双鹤华利药业有限公司 | 国药准字H41021681 | 250ml:12.5g | Category A (甲) | XB05XAT018B002010103026 | NHSA |
| 开封制药(集团)有限公司 | 国药准字H41022437 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010103139 | NHSA |
| 信合援生制药股份有限公司 | 国药准字H41025382 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010103140 | NHSA |
| 海南制药厂有限公司制药二厂 | 国药准字H41023005 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010103141 | NHSA |
| 上海浦津林州制药有限公司 | 国药准字H41022238 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010103143 | NHSA |
| 河南天方华中药业有限公司 | 国药准字H41022748 | 250ml:12.5g | Category A (甲) | XB05XAT018B002010103198 | NHSA |
| 上海现代哈森(商丘)药业有限公司 | 国药准字H20043781 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010103202 | NHSA |
| 遂成药业股份有限公司 | 国药准字H41021050 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010103204 | NHSA |
| 国药集团容生制药有限公司 | 国药准字H20013007 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010103205 | NHSA |
| 中嘉生物科技(湖北省)有限公司 | 国药准字H20053950 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010103377 | NHSA |
| 辽源市泓源制药有限公司 | 国药准字H22026292 | 100ml:5g | Category A (甲) | XB05XAT018B002010103510 | NHSA |
| 通化华夏药业有限责任公司 | 国药准字H22021382 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010103556 | NHSA |
| 哈尔滨三联药业股份有限公司 | 国药准字H20083270 | 10ml：0.2g | Category A (甲) | XB05XAT018B002010103662 | NHSA |
| 黑龙江博宇制药有限公司 | 国药准字H20258006 | 50ml:4.2g | Category A (甲) | XB05XAT018B002010103745 | NHSA |
| 黑龙江省格润药业有限责任公司 | 国药准字H23022197 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010103820 | NHSA |
| 华润双鹤利民药业(济南)有限公司 | 国药准字H20044251 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010103973 | NHSA |
| 山东华鲁制药有限公司 | 国药准字H20194056 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010104098 | NHSA |
| 山东华信制药集团股份有限公司 | 国药准字H37023877 | 250ml:12.5g | Category A (甲) | XB05XAT018B002010104100 | NHSA |
| 山东科伦药业有限公司 | 国药准字H20033846 | 100ml:5g | Category A (甲) | XB05XAT018B002010104114 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20163193 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010104127 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20153284 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010104145 | NHSA |
| 山东新华制药股份有限公司 | 国药准字H20227054 | 10ml:0.84g | Category A (甲) | XB05XAT018B002010104187 | NHSA |
| 山东圣鲁制药有限公司 | 国药准字H37021234 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010104207 | NHSA |
| 安徽双鹤药业有限责任公司 | 国药准字H20033779 | 250ml∶12.5g | Category A (甲) | XB05XAT018B002010104346 | NHSA |
| 上海华源安徽锦辉制药有限公司 | 国药准字H34021512 | 100ml:5g | Category A (甲) | XB05XAT018B002010104435 | NHSA |
| 杭州民生药业股份有限公司 | 国药准字H20255855 | 50ml:4.2g | Category A (甲) | XB05XAT018B002010104494 | NHSA |
| 浙江天瑞药业有限公司 | 国药准字H20033040 | 250ml:12.5g | Category A (甲) | XB05XAT018B002010104718 | NHSA |
| 湖南金健药业有限责任公司 | 国药准字H20023522 | 250ml:12.5g | Category A (甲) | XB05XAT018B002010104936 | NHSA |
| 湖南康源制药有限公司 | 国药准字H43020168 | 250ml:12.5g | Category A (甲) | XB05XAT018B002010104947 | NHSA |
| 广东科泓药业有限公司 | 国药准字H43020453 | 250ml:12.5g | Category A (甲) | XB05XAT018B002010104948 | NHSA |
| 湖南科伦制药有限公司 | 国药准字H20057980 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010105006 | NHSA |
| 回音必集团江西东亚制药有限公司 | 国药准字H36020284 | 100ml:5g | Category A (甲) | XB05XAT018B002010105251 | NHSA |
| 江西璟瑞药业有限公司 | 国药准字H20255390 | 10ml:0.42g | Category A (甲) | XB05XAT018B002010105252 | NHSA |
| 辽宁民康制药有限公司 | 国药准字H20013134 | 250ml:12.5g | Category A (甲) | XB05XAT018B002010105319 | NHSA |
| 贵州天地药业有限责任公司 | 国药准字H52020416 | 250ml:12.5g | Category A (甲) | XB05XAT018B002010105531 | NHSA |
| 昆明南疆制药有限公司 | 国药准字H53020470 | 100ml:5g | Category A (甲) | XB05XAT018B002010105597 | NHSA |
| 昆明市宇斯药业有限责任公司 | 国药准字H53020841 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010105604 | NHSA |
| 瑞丽市畹町民鑫制药有限公司 | 国药准字H20083484 | 100ml:5.0g | Category A (甲) | XB05XAT018B002010105621 | NHSA |
| 海南倍特药业有限公司 | 国药准字H20258017 | 10ml:0.84g | Category A (甲) | XB05XAT018B002010105791 | NHSA |
| 甘肃扶正药业科技股份有限公司 | 国药准字H62020214 | 100ml:5g | Category A (甲) | XB05XAT018B002010105856 | NHSA |
| 甘肃兰药药业有限公司 | 国药准字H62020679 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010105863 | NHSA |
| 陇药皇甫谧制药股份有限公司 | 国药准字H62020413 | 250ml:12.5g | Category A (甲) | XB05XAT018B002010105874 | NHSA |
| 华夏生生药业(北京)有限公司 | 国药准字H20253516 | 10ml ∶ 0.84g | Category A (甲) | XB05XAT018B002010109910 | NHSA |
| 嘉实(湖南)医药科技有限公司 | 国药准字H20244838 | 100ml:1.4g | Category A (甲) | XB05XAT018B002010183048 | NHSA |
| 山东华鲁制药有限公司 | 国药准字H20258191 | 10ml:0.42g | Category A (甲) | XB05XAT018B002010183083 | NHSA |
| 成都欣捷高新技术开发股份有限公司 | 国药准字H20263843 | 10ml∶0.42g | Category A (甲) | XB05XAT018B002010183325 | NHSA |
| 陕西丽彩药业有限公司 | 国药准字H20263612 | 10ml:0.42g | Category A (甲) | XB05XAT018B002010183540 | NHSA |
| 南京恩泰医药科技有限公司 | 国药准字H20255298 | 10ml:0.84g | Category A (甲) | XB05XAT018B002010183607 | NHSA |
| 北京民康百草医药科技有限公司 | 国药准字H20255278 | 10ml:0.42g | Category A (甲) | XB05XAT018B002010183644 | NHSA |
| 南京赛瑞谱顿制药有限公司 | 国药准字H20264064 | 10ml:0.42g | Category A (甲) | XB05XAT018B002010183995 | NHSA |
| 绪必迪药业(河北)有限公司 | 国药准字H20256299 | 10ml:0.84g | Category A (甲) | XB05XAT018B002010184272 | NHSA |
| 合肥源丰顺医药科技有限公司 | 国药准字H20258082 | 10ml:0.84g | Category A (甲) | XB05XAT018B002010184751 | NHSA |
| 江西泰吉立生物医药科技有限公司 | 国药准字H20265024 | 10ml:0.42g | Category A (甲) | XB05XAT018B002010184945 | NHSA |
| 广州合和医药有限公司 | 国药准字H20254426 | 10ml:0.42g | Category A (甲) | XB05XAT018B002010185013 | NHSA |
| 江苏宝东医药科技有限公司 | 国药准字H20264711 | 50ml:4.2g | Category A (甲) | XB05XAT018B002010185577 | NHSA |
| 华润双鹤药业股份有限公司 | 国药准字H11020789 | 250ml:12.5g | Category A (甲) | XB05XAT018B002010200144 | NHSA |
| 东莞市普济药业有限公司 | 国药准字H20064481 | 250ml:12.5g | Category A (甲) | XB05XAT018B002010200251 | NHSA |
| 津药和平(天津)制药有限公司 | 国药准字H12020998 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010200874 | NHSA |
| 中国大冢制药有限公司 | 国药准字H20183434 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010200967 | NHSA |
| 重庆药友制药有限责任公司 | 国药准字H50020782 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010201066 | NHSA |
| 江苏正大丰海制药有限公司 | 国药准字H32026207 | 250ml:12.5g | Category A (甲) | XB05XAT018B002010201521 | NHSA |
| 海南倍特药业有限公司 | 国药准字H32022332 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010201708 | NHSA |
| 江苏朗欧药业有限公司 | 国药准字H32022138 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010201723 | NHSA |
| 湖北天圣药业有限公司 | 国药准字H42020420 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010201842 | NHSA |
| 武汉爱民制药股份有限公司 | 国药准字H42021873 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010201924 | NHSA |
| 四川美大康华康药业有限公司 | 国药准字H51021422 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010202087 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20043738 | 100ml:5g | Category A (甲) | XB05XAT018B002010202180 | NHSA |
| 陕西同康药业有限公司 | 国药准字H61020268 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010202434 | NHSA |
| 陕西顿斯制药有限公司 | 国药准字H61022498 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010202503 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H13022134 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010202662 | NHSA |
| 石家庄四药有限公司 | 国药准字H13023197 | 250ml:12.5g | Category A (甲) | XB05XAT018B002010202763 | NHSA |
| 山西华卫药业有限公司 | 国药准字H14023901 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010202887 | NHSA |
| 山西太原药业有限公司 | 国药准字H14022070 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010202944 | NHSA |
| 石药银湖制药有限公司 | 国药准字H14022190 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010202954 | NHSA |
| 上海锦帝九州药业(安阳)有限公司 | 国药准字H41023047 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010202994 | NHSA |
| 郑州卓峰制药有限公司 | 国药准字H41025292 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010203013 | NHSA |
| 信合援生制药股份有限公司 | 国药准字H41025382 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010203140 | NHSA |
| 上海浦津林州制药有限公司 | 国药准字H41022238 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010203143 | NHSA |
| 上海现代哈森(商丘)药业有限公司 | 国药准字H20043781 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010203202 | NHSA |
| 遂成药业股份有限公司 | 国药准字H41021050 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010203204 | NHSA |
| 哈尔滨三联药业股份有限公司 | 国药准字H20083269 | 10ml：0.5g | Category A (甲) | XB05XAT018B002010203662 | NHSA |
| 华润双鹤利民药业(济南)有限公司 | 国药准字H20044251 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010203973 | NHSA |
| 山东华鲁制药有限公司 | 国药准字H20194056 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010204098 | NHSA |
| 山东科伦药业有限公司 | 国药准字H20033846 | 100ml:5g | Category A (甲) | XB05XAT018B002010204114 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20153284 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010204145 | NHSA |
| 山东新华制药股份有限公司 | 国药准字H20227054 | 10ml:0.84g | Category A (甲) | XB05XAT018B002010204187 | NHSA |
| 山东圣鲁制药有限公司 | 国药准字H37021234 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010204207 | NHSA |
| 杭州民生药业股份有限公司 | 国药准字H20255855 | 50ml:4.2g | Category A (甲) | XB05XAT018B002010204494 | NHSA |
| 浙江天瑞药业有限公司 | 国药准字H20033040 | 250ml:12.5g | Category A (甲) | XB05XAT018B002010204718 | NHSA |
| 湖南康源制药有限公司 | 国药准字H43020168 | 250ml:12.5g | Category A (甲) | XB05XAT018B002010204947 | NHSA |
| 广东科泓药业有限公司 | 国药准字H43020453 | 250ml:12.5g | Category A (甲) | XB05XAT018B002010204948 | NHSA |
| 湖南科伦制药有限公司 | 国药准字H20057980 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010205006 | NHSA |
| 辽宁民康制药有限公司 | 国药准字H20013134 | 250ml:12.5g | Category A (甲) | XB05XAT018B002010205319 | NHSA |
| 昆明市宇斯药业有限责任公司 | 国药准字H53020841 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010205604 | NHSA |
| 陕西丽彩药业有限公司 | 国药准字H20263612 | 10ml:0.42g | Category A (甲) | XB05XAT018B002010283540 | NHSA |
| 北京民康百草医药科技有限公司 | 国药准字H20255278 | 10ml:0.42g | Category A (甲) | XB05XAT018B002010283644 | NHSA |
| 南京赛瑞谱顿制药有限公司 | 国药准字H20264064 | 10ml:0.42g | Category A (甲) | XB05XAT018B002010283995 | NHSA |
| 广州合和医药有限公司 | 国药准字H20254426 | 10ml:0.42g | Category A (甲) | XB05XAT018B002010285013 | NHSA |
| 海南倍特药业有限公司 | 国药准字H32022332 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010301708 | NHSA |
| 江苏朗欧药业有限公司 | 国药准字H32022138 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010301723 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20043738 | 100ml:5g | Category A (甲) | XB05XAT018B002010302180 | NHSA |
| 陕西顿斯制药有限公司 | 国药准字H61022498 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010302503 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H13022134 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010302662 | NHSA |
| 石家庄四药有限公司 | 国药准字H13023197 | 250ml:12.5g | Category A (甲) | XB05XAT018B002010302763 | NHSA |
| 海南制药厂有限公司制药二厂 | 国药准字H41023005 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010303141 | NHSA |
| 安徽双鹤药业有限责任公司 | 国药准字H20033779 | 250ml∶12.5g | Category A (甲) | XB05XAT018B002010304346 | NHSA |
| 湖南康源制药有限公司 | 国药准字H43020168 | 250ml:12.5g | Category A (甲) | XB05XAT018B002010304947 | NHSA |
| 湖南科伦制药有限公司 | 国药准字H20057980 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010305006 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20043738 | 100ml:5g | Category A (甲) | XB05XAT018B002010402180 | NHSA |
| 陕西顿斯制药有限公司 | 国药准字H61022498 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010402503 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H13022134 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010402662 | NHSA |
| 石家庄四药有限公司 | 国药准字H13023197 | 250ml:12.5g | Category A (甲) | XB05XAT018B002010402763 | NHSA |
| 湖南科伦制药有限公司 | 国药准字H20057980 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010405006 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20043738 | 100ml:5g | Category A (甲) | XB05XAT018B002010502180 | NHSA |
| 陕西顿斯制药有限公司 | 国药准字H61022498 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010502503 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H13022134 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010502662 | NHSA |
| 湖南科伦制药有限公司 | 国药准字H20057980 | 10ml:0.5g | Category A (甲) | XB05XAT018B002010505006 | NHSA |
| 东莞市普济药业有限公司 | 国药准字H20064480 | 100ml:5g | Category A (甲) | XB05XAT018B002020100251 | NHSA |
| 天津金耀药业有限公司 | 国药准字H12020907 | 20ml:1g | Category A (甲) | XB05XAT018B002020100874 | NHSA |
| 天圣制药集团股份有限公司 | 国药准字H20057635 | 250ml:12.5g | Category A (甲) | XB05XAT018B002020101055 | NHSA |
| 重庆药友制药有限责任公司 | 国药准字H50021334 | 100ml:5g | Category A (甲) | XB05XAT018B002020101066 | NHSA |
| 江苏淮安双鹤药业有限责任公司 | 国药准字H32022429 | 250ml:12.5g | Category A (甲) | XB05XAT018B002020101449 | NHSA |
| 江苏正大丰海制药有限公司 | 国药准字H32025853 | 100ml:5g | Category A (甲) | XB05XAT018B002020101521 | NHSA |
| 四川太平洋药业有限责任公司 | 国药准字H32022333 | 250ml:12.5g | Category A (甲) | XB05XAT018B002020101708 | NHSA |
| 武汉福星生物药业有限公司 | 国药准字H42022235 | 10ml:0.5g | Category A (甲) | XB05XAT018B002020101799 | NHSA |
| 湖北天圣药业有限公司 | 国药准字H20258187 | 10ml:0.42g | Category A (甲) | XB05XAT018B002020101842 | NHSA |
| 武汉久安药业有限公司 | 国药准字H42020501 | 250ml:12.5g | Category A (甲) | XB05XAT018B002020101949 | NHSA |
| 四川美大康华康药业有限公司 | 国药准字H51021423 | 100ml:5g | Category A (甲) | XB05XAT018B002020102087 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20043739 | 250ml:12.5g | Category A (甲) | XB05XAT018B002020102180 | NHSA |
| 西安京西双鹤药业有限公司 | 国药准字H61020257 | 250ml:12.5g | Category A (甲) | XB05XAT018B002020102492 | NHSA |
| 河北美图制药有限责任公司 | 国药准字H13022004 | 20ml:1g | Category A (甲) | XB05XAT018B002020102598 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H13022312 | 250ml:12.5g | Category A (甲) | XB05XAT018B002020102662 | NHSA |
| 石家庄四药有限公司 | 国药准字H20247111 | 50ml:4.2g | Category A (甲) | XB05XAT018B002020102763 | NHSA |
| 国药集团容生制药有限公司 | 国药准字H20013007 | 10ml:0.5g | Category A (甲) | XB05XAT018B002020103205 | NHSA |
| 辽源市泓源制药有限公司 | 国药准字H22026291 | 250ml:12.5g | Category A (甲) | XB05XAT018B002020103510 | NHSA |
| 哈尔滨三联药业股份有限公司 | 国药准字H23020617 | 250ml:12.5g | Category A (甲) | XB05XAT018B002020103662 | NHSA |
| 华润双鹤利民药业(济南)有限公司 | 国药准字H20258005 | 10ml:0.84g | Category A (甲) | XB05XAT018B002020103973 | NHSA |
| 山东华鲁制药有限公司 | 国药准字H20194057 | 20ml:1g | Category A (甲) | XB05XAT018B002020104098 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20013153 | 250ml:12.5g | Category A (甲) | XB05XAT018B002020104127 | NHSA |
| 山东齐都药业有限公司 | 国药准字H37020767 | 250ml:12.5g | Category A (甲) | XB05XAT018B002020104145 | NHSA |
| 安徽双鹤药业有限责任公司 | 国药准字H20227123 | 500ml:7g | Category A (甲) | XB05XAT018B002020104346 | NHSA |
| 上海华源安徽锦辉制药有限公司 | 国药准字H34021488 | 250ml:12.5g | Category A (甲) | XB05XAT018B002020104435 | NHSA |
| 浙江天瑞药业有限公司 | 国药准字H20033115 | 100ml:5g | Category A (甲) | XB05XAT018B002020104718 | NHSA |
| 湖南科伦制药有限公司 | 国药准字H20258007 | 10ml:0.42g | Category A (甲) | XB05XAT018B002020104948 | NHSA |
| 回音必集团江西东亚制药有限公司 | 国药准字H36020283 | 250ml:12.5g | Category A (甲) | XB05XAT018B002020105251 | NHSA |
| 昆明南疆制药有限公司 | 国药准字H53020471 | 250ml:12.5g | Category A (甲) | XB05XAT018B002020105597 | NHSA |
| 瑞丽市畹町民鑫制药有限公司 | 国药准字H20046768 | 250ml:12.5g | Category A (甲) | XB05XAT018B002020105621 | NHSA |
| 海南倍特药业有限公司 | 国药准字H20258018 | 10ml:0.42g | Category A (甲) | XB05XAT018B002020105791 | NHSA |
| 甘肃扶正药业科技股份有限公司 | 国药准字H62020215 | 250ml:12.5g | Category A (甲) | XB05XAT018B002020105856 | NHSA |
| 山东华鲁制药有限公司 | 国药准字H20258190 | 10ml:0.84g | Category A (甲) | XB05XAT018B002020183083 | NHSA |
| 陕西丽彩药业有限公司 | 国药准字H20263613 | 50ml:4.2g | Category A (甲) | XB05XAT018B002020183540 | NHSA |
| 南京赛瑞谱顿制药有限公司 | 国药准字H20264065 | 10ml:0.84g | Category A (甲) | XB05XAT018B002020183995 | NHSA |
| 合肥源丰顺医药科技有限公司 | 国药准字H20258083 | 10ml:0.42g | Category A (甲) | XB05XAT018B002020184751 | NHSA |
| 江西泰吉立生物医药科技有限公司 | 国药准字H20265025 | 10ml:0.84g | Category A (甲) | XB05XAT018B002020184945 | NHSA |
| 武汉福星生物药业有限公司 | 国药准字H42022235 | 10ml:0.5g | Category A (甲) | XB05XAT018B002020201799 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20043739 | 250ml:12.5g | Category A (甲) | XB05XAT018B002020202180 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H13022312 | 250ml:12.5g | Category A (甲) | XB05XAT018B002020202662 | NHSA |
| 石家庄四药有限公司 | 国药准字H20247111 | 50ml:4.2g | Category A (甲) | XB05XAT018B002020202763 | NHSA |
| 开封制药(集团)有限公司 | 国药准字H41022437 | 10ml:0.5g | Category A (甲) | XB05XAT018B002020203139 | NHSA |
| 华润双鹤利民药业(济南)有限公司 | 国药准字H20258005 | 10ml:0.84g | Category A (甲) | XB05XAT018B002020203973 | NHSA |
| 山东齐都药业有限公司 | 国药准字H37020767 | 250ml:12.5g | Category A (甲) | XB05XAT018B002020204145 | NHSA |
| 回音必集团江西东亚制药有限公司 | 国药准字H36020283 | 250ml:12.5g | Category A (甲) | XB05XAT018B002020205251 | NHSA |
| 昆明南疆制药有限公司 | 国药准字H53020471 | 250ml:12.5g | Category A (甲) | XB05XAT018B002020205597 | NHSA |
| 南京赛瑞谱顿制药有限公司 | 国药准字H20264065 | 10ml:0.84g | Category A (甲) | XB05XAT018B002020283995 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20043739 | 250ml:12.5g | Category A (甲) | XB05XAT018B002020302180 | NHSA |
| 石家庄四药有限公司 | 国药准字H20247111 | 50ml:4.2g | Category A (甲) | XB05XAT018B002020302763 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20043739 | 250ml:12.5g | Category A (甲) | XB05XAT018B002020402180 | NHSA |
| 石家庄四药有限公司 | 国药准字H20247111 | 50ml:4.2g | Category A (甲) | XB05XAT018B002020402763 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20043739 | 250ml:12.5g | Category A (甲) | XB05XAT018B002020502180 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20043739 | 250ml:12.5g | Category A (甲) | XB05XAT018B002020602180 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20043739 | 250ml:12.5g | Category A (甲) | XB05XAT018B002020702180 | NHSA |
| 重庆药友制药有限责任公司 | 国药准字H50021335 | 250ml:12.5g | Category A (甲) | XB05XAT018B002030101066 | NHSA |
| 江苏正大丰海制药有限公司 | 国药准字H20258141 | 50ml:4.2g | Category A (甲) | XB05XAT018B002030101521 | NHSA |
| 四川美大康华康药业有限公司 | 国药准字H51021424 | 250ml:12.5g | Category A (甲) | XB05XAT018B002030102087 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H20258009 | 10ml:0.42g | Category A (甲) | XB05XAT018B002030102662 | NHSA |
| 石家庄四药有限公司 | 国药准字H20253531 | 10ml:0.84g | Category A (甲) | XB05XAT018B002030102763 | NHSA |
| 国药集团容生制药有限公司 | 国药准字H20258193 | 10ml:0.84g | Category A (甲) | XB05XAT018B002030103205 | NHSA |
| 哈尔滨三联药业股份有限公司 | 国药准字H20247252 | 10ml:0.84g | Category A (甲) | XB05XAT018B002030103662 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20013153 | 250ml:12.5g | Category A (甲) | XB05XAT018B002030104127 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20247232 | 10ml:0.42g | Category A (甲) | XB05XAT018B002030104145 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20217127 | 100ml:1.4g | Category A (甲) | XB05XAT018B002030104435 | NHSA |
| 湖南科伦制药有限公司 | 国药准字H20258008 | 10ml:0.84g | Category A (甲) | XB05XAT018B002030104948 | NHSA |
| 回音必集团江西东亚制药有限公司 | 国药准字H20269156 | 50ml:4.2g | Category A (甲) | XB05XAT018B002030105251 | NHSA |
| 昆明南疆制药有限公司 | 国药准字H20247291 | 50ml:4.2g | Category A (甲) | XB05XAT018B002030105597 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H20258009 | 10ml:0.42g | Category A (甲) | XB05XAT018B002030202662 | NHSA |
| 石家庄四药有限公司 | 国药准字H20253531 | 10ml:0.84g | Category A (甲) | XB05XAT018B002030202763 | NHSA |
| 国药集团容生制药有限公司 | 国药准字H20258193 | 10ml:0.84g | Category A (甲) | XB05XAT018B002030203205 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H20258009 | 10ml:0.42g | Category A (甲) | XB05XAT018B002030302662 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H20258004 | 10ml:0.84g | Category A (甲) | XB05XAT018B002040102662 | NHSA |
| 石家庄四药有限公司 | 国药准字H20253723 | 10ml:0.42g | Category A (甲) | XB05XAT018B002040102763 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20163193 | 10ml:0.5g | Category A (甲) | XB05XAT018B002040104127 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20247233 | 10ml:0.84g | Category A (甲) | XB05XAT018B002040104145 | NHSA |
| 安徽誉恒生物科技有限公司 | 国药准字H20217126 | 250ml:3.5g | Category A (甲) | XB05XAT018B002040104435 | NHSA |
| 广东科泓药业有限公司 | 国药准字H20258026 | 50ml:4.2g | Category A (甲) | XB05XAT018B002040104948 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H20258004 | 10ml:0.84g | Category A (甲) | XB05XAT018B002040202662 | NHSA |
| 石家庄四药有限公司 | 国药准字H20253723 | 10ml:0.42g | Category A (甲) | XB05XAT018B002040202763 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H20258004 | 10ml:0.84g | Category A (甲) | XB05XAT018B002040302662 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H20258043 | 50ml:4.2g | Category A (甲) | XB05XAT018B002050102662 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20247251 | 50ml:4.2g | Category A (甲) | XB05XAT018B002050104145 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20269146 | 100ml:1.4g | Category A (甲) | XB05XAT018B002060104145 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 10 filings and 6 distinct first applicants.
Supplement 6 · Generic 4
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 江苏淮安双鹤药业有限责任公司 | CYHB2401308 | Supplement | 2024/08/22 | Not stated by source | CDE |
| 山西晟泽元生物科技有限公司;山西诺成制药有限公司 | CYHS2602252 | Generic | 2026/09/09 | Not stated by source | CDE |
| 焦作市民康药业有限公司 | CYHS2602234 | Generic | 2026/09/08 | Not stated by source | CDE |
| 焦作市民康药业有限公司 | CYHS2602233 | Generic | 2026/09/08 | Not stated by source | CDE |
| 辰欣药业股份有限公司 | CYHB2650037 | Supplement | 2026/02/02 | Not stated by source | CDE |
| 遂成药业股份有限公司 | CYHB2650012 | Supplement | 2026/01/09 | Not stated by source | CDE |
| 遂成药业股份有限公司 | CYHB2650011 | Supplement | 2026/01/09 | Not stated by source | CDE |
| 辰欣药业股份有限公司 | CYHB2550361 | Supplement | 2025/11/11 | Not stated by source | CDE |
| 辰欣药业股份有限公司 | CYHB2550360 | Supplement | 2025/11/11 | Not stated by source | CDE |
| 安徽双鹤药业有限责任公司 | CYHS2501161 | Generic | 2025/03/25 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 3 filings and 2 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 山西晟泽元生物科技有限公司;山西诺成制药有限公司 | CYHS2602252 | Generic | 2026/09/09 | Not stated by source | CDE |
| 焦作市民康药业有限公司 | CYHS2602234 | Generic | 2026/09/08 | Not stated by source | CDE |
| 焦作市民康药业有限公司 | CYHS2602233 | Generic | 2026/09/08 | Not stated by source | CDE |
API registrations
Non-component matches: 17 companies with A status and 9 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 碳酸氢钠 | 上海锦帝九州药业（安阳）有限公司 | Y20260000644 | I | Exact ingredient | 2026/08/17 | CDE |
| 碳酸氢钠 | 云鹏医药集团有限公司 | Y20260000604 | I | Exact ingredient | 2026/08/12 | CDE |
| 碳酸氢钠 | 焦作市民康药业有限公司 | Y20260000242 | I | Exact ingredient | 2026/04/13 | CDE |
| 碳酸氢钠 | 浙江耐司康药业有限公司 | Y20250000808 | I | Exact ingredient | 2025/08/20 | CDE |
| 碳酸氢钠 | 山东新时代药业有限公司 | Y20250000639 | A | Exact ingredient | 2026/10/16 | CDE |
| 碳酸氢钠 | 开封制药（集团）有限公司 | Y20240000659 | A | Exact ingredient | 2026/04/01 | CDE |
| 碳酸氢钠 | 山东新时代药业有限公司 | Y20240000414 | A | Exact ingredient | 2025/12/08 | CDE |
| 碳酸氢钠 | 南阳普康恒旺药业有限公司 | Y20240000212 | A | Exact ingredient | 2025/10/14 | CDE |
| 碳酸氢钠 | 白云山东泰商丘药业有限公司 | Y20220001248 | A | Exact ingredient | 2025/03/14 | CDE |
| 碳酸氢钠 | Novabay Pte Ltd | Y20220001293 | A | Exact ingredient | 2025/10/10 | CDE |
| 碳酸氢钠 | 山东齐都药业有限公司 | Y20220001307 | A | Exact ingredient | 2025/05/06 | CDE |
| 碳酸氢钠 | 天津海光科技发展股份有限公司 | Y20210001192 | A | Exact ingredient | 2025/12/14 | CDE |
| 碳酸氢钠 | VM CHEMICALS | Y20210000154 | A | Exact ingredient | 2024/03/19 | CDE |
| 碳酸氢钠 | 江苏正大丰海制药有限公司 | Y20210000020 | A | Exact ingredient | 2023/07/15 | CDE |
| 碳酸氢钠 | SOLVAY QUíMICA S.L. | Y20200000251 | I | Exact ingredient | 2024/11/07 | CDE |
| 碳酸氢钠 | 河南精康制药有限公司 | Y20190001111 | A | Exact ingredient | 2026/05/09 | CDE |
| 碳酸氢钠 | Sudeep Pharma Limited | Y20190001136 | A | Exact ingredient | 2026/08/12 | CDE |
| 碳酸氢钠 | 新兴凌云医药化工有限公司 | Y20190009679 | A | Exact ingredient | 2025/02/08 | CDE |
| 碳酸氢钠 | 新兴凌云医药化工有限公司 | Y20190009678 | A | Exact ingredient | 2025/02/08 | CDE |
| 碳酸氢钠 | 河北华晨药业集团有限公司 | Y20190008761 | A | Exact ingredient | 2025/08/23 | CDE |
| 碳酸氢钠 | 南昌白云药业有限公司 | Y20190006843 | A | Exact ingredient | 2025/02/07 | CDE |
| 碳酸氢钠 | 自贡鸿鹤制药有限责任公司 | Y20190001479 | A | Exact ingredient | 2025/03/29 | CDE |
| 碳酸氢钠 | 哈药集团制药总厂 | Y20190001202 | A | Exact ingredient | 2024/08/16 | CDE |
| 碳酸氢钠（供口服用） | 自贡鸿鹤制药有限责任公司 | Y20180000666 | I | Exact ingredient | 2019/09/24 | CDE |
| 碳酸氢钠 | 新兴凌云医药化工有限公司 | Y20190000612 | I | Exact ingredient | 2019/08/12 | CDE |
| 碳酸氢钠 | Solvay Peroxythai Limited | Y20190000236 | A | Exact ingredient | 2026/01/16 | CDE |
| 碳酸氢钠 | 新兴凌云医药化工有限公司 | Y20180000427 | I | Exact ingredient | — | CDE |
| 碳酸氢钠 | 新兴凌云医药化工有限公司 | Y20180000426 | I | Exact ingredient | — | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/10 07:23. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
-
2026/11/07No longer listed under review
嘉实（湖南）医药科技有限公司;杭州民生药业股份有限公司
CYHB2601895
Fact date: 2026/11/07 · Site observation date: 2026/11/07
Accepted: 2026/10/15
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/06 (approval no.: —; approval date: 2026/11/05); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 41
NMPA · Table row 41 ↗ View source ↗ -
2026/11/05Supplement delivery
嘉实（湖南）医药科技有限公司
CYHB2601895
Fact date: 2026/11/05 · Publication date: 2026/11/06 · Site observation date: 2026/11/06
Supplemental application; excluded from new marketing approvals.
View source · Table row 41 ↗ -
2026/10/26Marketing application approved
江苏迪赛诺制药有限公司
CYHS2500860 · 国药准字H20266414
Fact date: 2026/10/26 · Publication date: 2026/10/27 · Site observation date: 2026/11/03
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 33 ↗ -
2026/10/15Accepted
嘉实（湖南）医药科技有限公司;杭州民生药业股份有限公司
CYHB2601895
Fact date: 2026/10/15 · Site observation date: 2026/10/22
View source ↗ -
2026/09/09Accepted
山西晟泽元生物科技有限公司;山西诺成制药有限公司
CYHS2602252
Fact date: 2026/09/09 · Site observation date: 2026/10/22
View source ↗ -
2026/09/08Accepted
-
2026/09/08Accepted
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/10 07:27
- Chemical-drug catalogue
- Last successful update: 2026/11/10 07:23
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/10 07:25
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31
First index-page publication dates: 2026-10-26 to 2026-11-10; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/10 08:10 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 3/30; discovered pending details: 20. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Sodium Bicarbonate Injection
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Yearly
US$1,920
Billed every year
US$160 per month
Online subscriptions are not enabled. The form below registers interest; it does not charge or activate access.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
US$490
One payment · 12 months of access
Online comparison-table purchase is not enabled.
Billed by Creem, our merchant of record · Terms · Refund policy